HIKALBSEHIKAL LIMITED· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 26 Aug, 2026 · 13:18 IST

Sameer Hiremath appointed Chairman and Managing Director of Hikal

HIKAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.4%Reaction day
₹208.49
prior close
₹207.44
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.6%-1.0% vs market
Pharmaceuticals peers, median of 175sector+0.3%-0.8% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 0.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
+0.0
15m
+0.7
30m
+0.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.4+0.6-1.0+0.3-0.8
Next day
-2.1+0.4-2.4+0.4-2.4
2d
-2.2+0.7-2.8+0.7-2.9
3d
-3.3+1.0-4.2+1.0-4.2
4d
-4.6-0.0-4.5+0.5-5.1
5d
-3.8-0.6-3.2+0.7-4.5
1w
+6.7+0.7+6.0+1.1+5.5
15d
+7.9-1.2+9.2+0.9+7.0
1m
+1.1-0.9+2.0-0.6+1.7
2m
-7.3-9.0+1.7-5.8-1.5
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 175Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Hikal board appointed Sameer Hiremath as Chairman and Managing Director for 5 years from October 1, 2026 to September 30, 2031, subject to shareholder approval. Hiremath is currently Vice Chairman and MD, son of promoter Jai Hiremath, and has been with Hikal for nearly three decades.

Likely market impact

Internal leadership elevation ensures continuity. Signals formal succession within promoter family to the next generation.